Rembrandt M&A acted as exclusive financial advisor to Mohs Noord Holland B.V.

Netherlands-based company engaged in providing specialised dermatologic healthcare.Dr. J.M. Muche B.V. and Van Rengen B.V., dermatologists specialised in dermato-oncology, has acquired 100% of the shares in Mohs Klinieken Holding B.V., a Netherlands-based company engaged in providing specialised dermatologic healthcare, in a Management Buy-Out.

Rembrandt M&A

Advised in the sale of

Mohs Klinieken Holding B.V (Management buy out)

to

Dr. J.M. Muche B.V.

Healthcare

MidCap Alliance